{
  "title": "Drug Metabolism: The Importance of Child-Pugh Classification for Staging Hepatic Impairment",
  "itunes:title": "Drug Metabolism: The Importance of Child-Pugh Classification for Staging Hepatic Impairment",
  "pubDate": "Wed, 21 Jul 2021 16:00:00 +0000",
  "guid": "d23c5c6f-b128-4da6-9d6c-d13a819a6697",
  "link": "https://psychopharmacology.libsyn.com/drug-metabolism-the-importance-of-child-pugh-classification-for-staging-hepatic-impairment",
  "itunes:image": "",
  "description": "<p>This episode discusses the Child-Pugh scale to assess hepatic impairment. It also covers the FDA's position on the inclusion of drug metabolism data for various Child-Pugh stages and cirrhosis.</p> <p>Faculty: Jonathan Meyer, M.D.<br /> Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC099\"> <strong>Learn more about our memberships here</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/use-of-psychotropics-in-patients-with-hepatic-issues-2582?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC099\"> <strong>Earn 1 CME: Use of Psychotropics in Patients With Hepatic Issues</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/the-importance-of-child-pugh-classification-for-staging-hepatic-impairment-2582-5009?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC099\"> <strong>The Importance of Child-Pugh Classification for Staging Hepatic Impairment</strong></a></li> </ul>",
  "content:encoded": "<p>This episode discusses the Child-Pugh scale to assess hepatic impairment. It also covers the FDA's position on the inclusion of drug metabolism data for various Child-Pugh stages and cirrhosis.</p> <p>Faculty: Jonathan Meyer, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC099\"> Learn more about our memberships here</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/use-of-psychotropics-in-patients-with-hepatic-issues-2582?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC099\"> Earn 1 CME: Use of Psychotropics in Patients With Hepatic Issues</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/the-importance-of-child-pugh-classification-for-staging-hepatic-impairment-2582-5009?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC099\"> The Importance of Child-Pugh Classification for Staging Hepatic Impairment</a></li> </ul>",
  "enclosure": "",
  "itunes:duration": "07:07",
  "itunes:explicit": false,
  "itunes:keywords": "",
  "itunes:subtitle": "This episode discusses the Child-Pugh scale to assess hepatic impairment. It also covers the FDA's position on the inclusion of drug metabolism data for various Child-Pugh stages and cirrhosis. Faculty: Jonathan Meyer, M.D. Hosts: Jessica Diaz, M.D.;...",
  "itunes:episodeType": "full"
}